These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Biocompatible Au@Ag nanorod@ZIF-8 core-shell nanoparticles for surface-enhanced Raman scattering imaging and drug delivery.
    Author: Jiang P, Hu Y, Li G.
    Journal: Talanta; 2019 Aug 01; 200():212-217. PubMed ID: 31036175.
    Abstract:
    A surface-enhanced Raman scattering (SERS) imaging probe and drug carrier based on zeolitic imidazolate framework (ZIF-8)-coated Au@Ag core-shell nanorod has been developed. Strong Raman signal is generated by a reporter molecule of 4-aminothiophenol (4-ATP) adsorbed on Au@Ag core-shell nanorod, endowing the probe with function of SERS imaging. Further coating of ZIF-8 on Au@Ag core-shell nanorod offered high loading capacity for anti-cancer drugs, doxorubicin (DOX), as well as improved the stability and biocompatibility of the SERS tag due to the protection of ZIF-8 shell. After immobilization of folic acid onto the Au@Ag NRs4-ATP@ZIF-8, the SERS probes were successfully applied to the targeted SERS imaging of HeLa, MCF-7, LNCaP, QGY-7703, HCT116 and MDA-MB-231 cells with low cytotoxicity, and further applied to the image of tumor tissue of human colon cancer. In vitro cell cytotoxicity confirmed that DOX-loaded SERS probes had potential therapeutic effect compared with the free drug. All of these original results contribute to develop potential biocompatible nanosystem integrating diagnosis and therapy.
    [Abstract] [Full Text] [Related] [New Search]